{"id":1226,"date":"2026-06-24T19:45:00","date_gmt":"2026-06-24T10:45:00","guid":{"rendered":"https:\/\/india-marketing.jp\/?post_type=india-news&p=1226"},"modified":"2026-08-02T16:52:24","modified_gmt":"2026-08-02T07:52:24","slug":"honasa-fluence-pharma","status":"publish","type":"india-news","link":"https:\/\/india-marketing.jp\/en\/india-news\/honasa-fluence-pharma\/","title":{"rendered":"Beauty D2C Mamaearth's parent buys a network of 3,000 dermatologists, moves into the health market"},"content":{"rendered":"
\nThis article is based on what we could verify As of August 1, 2026<\/strong> in public records and news reports from India. India revises its tax rules and regulations frequently, and the details here may have changed since. When making an actual business decision, please check the latest information with primary sources such as the ministries responsible and local experts.\n<\/div>\n\n\n

India's leading beauty D2C player Honasa Consumer (the parent of Mamaearth) has acquired a majority stake (58%) in Fluence Pharma, which holds a prescription network of more than 3,000 dermatologists and hair specialists, for roughly 1.35 billion rupees, and is making a full-scale entry into the nutraceutical (health supplement) market through a newly formed wholly owned subsidiary, Honasa Health. The announcement came around June 23, 2026. It is a move to extend the brand and customer base built in beauty sideways into \"health\" by linking it to the medical channel of dermatologists. For Japanese companies working in D2C cosmetics or health foods, or food and supplement makers eyeing the Indian market, this is not simply news of an overseas M&A deal. The very pattern of a beauty brand buying a doctor network to enter an adjacent market can serve as either a reference or a competitive threat.<\/p>\n\n

What happened<\/h2>\n\n

Honasa Consumer announced it will acquire a 58% stake in Fluence Pharma, founded in 2012, for roughly 1.35 billion rupees. It reportedly plans to acquire the remaining 42% in stages over the next five to seven years. The acquisition is expected to close within about eight weeks of the announcement. Alongside this, Honasa has newly established Honasa Health, a wholly owned subsidiary that will run the B2C health supplement business.<\/p>\n\n

Fluence Pharma has been a company that delivers condition-specific supplements tailored to skin and hair conditions through dermatologists and hair specialists. Its flagship brands include Hair Fact, Skin Fact, and Pro Fact. Over the past decade, more than 3,000 dermatologists are said to have carried its products, and this \"prescription channel through doctors\" is precisely the core asset Honasa is putting cash toward acquiring.<\/p>\n\n

Background: why a beauty brand is buying a doctor network<\/h2>\n\n

Honasa Consumer has grown mainly around Mamaearth, its D2C cosmetics and personal care brand. It is a leading example of an emerging Indian consumer goods company that captured young people and families through social media and online sales as its starting point, and went on to go public. While a digitally native brand gains a huge volume of customer touchpoints and data, its products tend to lean on \"mood\" or \"image,\" creating a need to retroactively add functional backing and expert credibility, a challenge that D2C brands commonly face as they mature.<\/p>\n\n

Fluence Pharma, by contrast, is still small in scale. Its reported revenue for the most recent fiscal year stays in the range of about 370 million to 400 million rupees (\u20b937-40 crore, roughly \u00a5640 million to \u00a5700 million). Even so, its EBITDA margin is said to exceed 20%, making it highly profitable. And above all, it carries something social media advertising cannot buy: clinical-setting trust built up over years of \"prescriptions from 3,000 dermatologists.\" For Honasa, this fills the medical-side trust it lacked; for Fluence, Honasa fills the digital sales power and brand strength it lacked, a structure in which each side's weakness is filled by the other's strength.<\/p>\n\n

Honasa cites rising consumer awareness of nutrition, preventive care, and wellness as its reason for entering this market. Management positions nutraceuticals as \"the next growth phase after beauty and personal care,\" explaining that consumers are increasingly seeking care from the inside out. This acquisition is also part of Honasa's mid-term strategy, \"Honasa 3.0,\" positioning health as one of the pillars meant to double future revenue.<\/p>\n\n

Verified figures<\/h2>\n\n